Bevacizumab (Avastin) as an Adjunct to Vitrectomy in the Management of Severe Proliferative Diabetic Retinopathy: a Prospective Case Series.
Phase of Trial: Phase II
Latest Information Update: 09 Jan 2010
At a glance
- Drugs Bevacizumab (Primary)
- Indications Diabetic retinopathy
- Focus Adverse reactions
- 09 Jan 2010 New trial record